Roivant Sciences Ltd.: CEO Matthew Gline sold 76,171 shares

What happened Matthew Gline, CEO and director, reported a disposition of 76,171 shares on Sep 30, 2026. The filing shows the shares were net-settled by the issuer to satisfy tax withholding in connection with RSU vesting at $36.57 per share, totaling $2,785,573.

Key details

• Transaction date and price: Sep 30, 2026 at $36.57 per share.
• Shares involved: 76,171 shares; total value $2,785,573.
• Transaction code: F (payment of exercise price or tax liability).
• Footnote F1: "Represents the 'net settlement' by the Issuer of RSUs previously granted to the reporting person in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such RSUs."
• Form filed on Oct 2, 2026. Filing timeliness: not indicated as late in the filing.
• Shares owned after the transaction: not reported in the provided filing.

Why it may matter The filing indicates a net settlement of restricted stock units to cover tax withholding rather than an open-market sale. A filing does not show why the insider traded or why the company acted.